{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:33:55Z","timestamp":1770960835852,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ymgme.2013.02.011","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T00:16:13Z","timestamp":1361837773000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Improved Amino Acid, Bioenergetic Metabolite and Neurotransmitter Profiles following Human Amnion Epithelial Cell Transplant in Intermediate Maple Syrup Urine Disease Mice"],"prefix":"10.1016","volume":"109","author":[{"given":"Kristen J.","family":"Skvorak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Dorko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel","family":"Tahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C.","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gramignoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erland","family":"Arning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodoro","family":"Bottiglieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Michael","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.02.011_bb0005","first-page":"1971","volume":"vol. 2","author":"Chuang","year":"2001"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1542\/peds.34.4.454","article-title":"Maple syrup urine disease, with particular reference to dietotherapy","volume":"34","author":"Snyderman","year":"1964","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-6143.2005.01209.x","article-title":"Elective liver transplantation for the treatment of classical maple syrup urine disease","volume":"6","author":"Strauss","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0020","series-title":"Liver Transplantation \u2014 Technical Issues and Complications","author":"Skvorak","year":"2012"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2796.2012.02574.x","article-title":"Hepatocyte transplantation for inherited metabolic diseases of the liver","volume":"272","author":"Jorns","year":"2012","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbadis.2009.08.006","article-title":"Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)","volume":"1792","author":"Skvorak","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0035","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/mt.2009.99","article-title":"Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease","volume":"17","author":"Skvorak","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ymthe.2005.03.025","article-title":"Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria","volume":"12","author":"Hamman","year":"2005","journal-title":"Mol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2013.02.011_bb0045","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.3727\/000000006783982395","article-title":"Hepatocyte transplantation: clinical experience and potential for future use","volume":"15","author":"Strom","year":"2006","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.tp.0000231689.44266.ac","article-title":"Human hepatocyte transplantation: worldwide results","volume":"82","author":"Fisher","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0055","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1542\/peds.111.6.1262","article-title":"Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder","volume":"111","author":"Horslen","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0060","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the Crigler\u2013Najjar syndrome type I with hepatocyte transplantation","volume":"338","author":"Fox","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrgastro.2010.44","article-title":"Human hepatocyte transplantation: current experience and future challenges","volume":"7","author":"Dhawan","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e3283318e1c","article-title":"Hepatocyte transplantation for correction of inborn errors of metabolism","volume":"18","author":"Waelzlein","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0075","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3748\/wjg.14.3464","article-title":"Liver cell transplantation for Crigler\u2013Najjar syndrome type I: update and perspectives","volume":"14","author":"Lysy","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01e03s12","article-title":"Isolation of amniotic epithelial stem cells","volume":"3","author":"Miki","year":"2010","journal-title":"Curr. Protoc. Stem Cell Biol."},{"issue":"2","key":"10.1016\/j.ymgme.2013.02.011_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00441-012-1424-6","article-title":"Amniotic membrane: from structure and functions to clinical applications","volume":"349","author":"Mamede","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0090","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0095","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem cell characteristics of amniotic epithelial cells","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(81)91212-5","article-title":"Immunogenicity of human amniotic epithelial cells after transplantation into volunteers","volume":"2","author":"Akle","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12015-006-0020-0","article-title":"Amnion-derived pluripotent\/multipotent stem cells","volume":"2","author":"Miki","year":"2006","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0110","first-page":"307","article-title":"Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital","volume":"15","author":"Davis","year":"1910","journal-title":"Johns Hopkins Med. J."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.survophthal.2003.10.004","article-title":"The amniotic membrane in ophthalmology","volume":"49","author":"Dua","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0120","first-page":"43","article-title":"Transplantation of amniotic epithelial membranes in patients with mucopolysaccharidoses","volume":"2","author":"Akle","year":"1985","journal-title":"Exp. Clin. Immunogenet."},{"issue":"141","key":"10.1016\/j.ymgme.2013.02.011_bb0125","article-title":"Treatment of patients with Niemann\u2013Pick type is using repeated amniotic epithelial cells implantation: correction of aggregation and coagulation abnormalities","volume":"36","author":"Cerneca","year":"1997","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.1320220219","article-title":"A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases","volume":"22","author":"Yeager","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0135","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.24255","article-title":"Hepatic differentiation of amnion epithelial cells","volume":"53","author":"Marongiu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-59745-201-4_13","article-title":"Production of hepatocyte-like cells from human amnion","volume":"481","author":"Miki","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.ymgme.2013.02.011_bb0145","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.26150","article-title":"Placental stem cell corrections of murine intermediate maple syrup urine disease","volume":"57","author":"Skvorak","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W","article-title":"Brain metabolism of branched-chain amino acids","volume":"21","author":"Yudkoff","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0160","doi-asserted-by":"crossref","first-page":"1531S","DOI":"10.1093\/jn\/135.6.1531S","article-title":"Brain amino acid requirements and toxicity: the example of leucine","volume":"135","author":"Yudkoff","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1046\/j.1471-4159.1998.70031001.x","article-title":"Alpha-ketoisocaproate alters the production of both lactate and aspartate from [U-13C]glutamate in astrocytes: a 13C NMR study","volume":"70","author":"McKenna","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0006-291X(83)90799-4","article-title":"Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease","volume":"114","author":"Tribble","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","article-title":"Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease","volume":"82","author":"Schonberger","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10545-009-1086-z","article-title":"Animal models of maple syrup urine disease","volume":"32","author":"Skvorak","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.02.011_bb0185","series-title":"Genotyping Protocols Database","author":"JAX","year":"2009"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0190","series-title":"Techniques in Diagnostic Human Biochemical Genetics","first-page":"87","author":"Slocum","year":"1991"},{"key":"10.1016\/j.ymgme.2013.02.011_bb0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nbd.2005.11.006","article-title":"Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells","volume":"22","author":"Ogburn","year":"2006","journal-title":"Neurobiol. Dis."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T08:25:06Z","timestamp":1644395106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1096719213000693"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.02.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Amino Acid, Bioenergetic Metabolite and Neurotransmitter Profiles following Human Amnion Epithelial Cell Transplant in Intermediate Maple Syrup Urine Disease Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}